OTOnur Tuncer

Onur Tuncer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Onur Tuncer has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    18F-FDG PET radiomics model for predicting TARE response in patients with colorectal cancer liver metastases

    by Osman Melih Topcuoglu, Onur Tuncer, Muge Oral, Ayşegul Gormez, Turkay Toklu, Nalan Alan Selcuk

    Purpose: Predicting treatment response in patients with colorectal cancer liver metastases (CRCLM) who have undergone transarterial radioembolization (TARE) based on pre-procedural fluorine-18-fluoro-deoxy glucose positron emission tomography ( 18 F-FDG PET) radiomics and clinical information. Materials and methods: Patients with CRCLM who underwent TARE, between March 2015 and May 2025, were consecutively included. Largest tumors were segmented semiautomatically using pre-procedural 18 F-FDG PET images. Radiomics features were extracted, clinical information were collected. Two datasets were created comprising radiomics-only and clinico-radiomic features. Datasets were divided 60:40 for training and testing. Top 5 features were selected based on feature importances. Random Forest, Extreme Gradient Boosting, Logistic Regression models were trained. Test-set area under the curves (AUCs) for predicting post-treatment target lesion local progression were calculated and compared using DeLong’s test. Sensitivity, specificity, accuracy and F1 scores were calculated at the optimal cut-offs. Results: Seventy-four patients out of 96 patients were included. Top five selected features in the radiomics-only dataset were Coarseness, IMC1, Zone Entropy, Size-Zone Non-Uniformity, and Strength. In the clinico-radiomic dataset, AST and ALT levels were substituted among the top five features. Radiomics-only features demonstrated AUCs ranging from 0.90 (95% CI 0.71–1) to 0.81 (95% CI 0.51–1) in the test-set while clinico-radiomics dataset AUCs varied between 0.88 (95% CI 0.51–1) and 0.84 (0.62–1). Conclusion: 18 F-FDG PET radiomics based models can predict the local response to TARE in patients with CRCLM, in this series.


  • DSC MR Perfusion at 7T MRI: An Initial Single-Center Study for Validity and Practicability

    by Clare E. Buntrock, Ceren Dinçer, Onur Tuncer, Matthew White, Alexis Swensen, Mark Folkertsma, Can Özütemiz

    BACKGROUND AND PURPOSE: DSC perfusion is an advanced imaging technique routinely used at 1.5T and 3T MRI. However, its utility is not well known in 7T MRI systems. We aim to evaluate if DSC perfusion is a valid and practicable tool at 7T MRI. MATERIALS AND METHODS: A successful DSC perfusion was performed in 9 patients with an FDA-approved 7T MRI system (Siemens Terra with 1tx/32rx Nova head coil) in 2023. Half-dose contrast was administered by hand, followed by saline flush. Acquisition was initiated 45 seconds before contrast injection. Voxel size was 1.5 × 1.5 × 1.6 mm3. Perfusion maps were generated by using either SyngoVia or DynaSuite software. Parameters including relative CBV (rCBV), relative CBF (rCBF), relative MTT (rMTT), and relative TTP (rTTP) were measured in 5 anatomic locations bilaterally (precentral gyrus, middle frontal gyrus, corona radiata, thalamus, occipital cortex) and enhancing lesions if present. Normalized ratios of rCBV (nrCBV), rCBF (nrCBF), rMTT (nrMTT), and rTTP (nrTTP) were calculated and compared on boxplots. Two neuroradiologists reviewed each scan visually by using a 5-point Likert scale regarding imaging quality and artifacts. Qualitative and quantitative assessments were made on DSC perfusion in cases with enhanced target lesions. RESULTS: Uploading the source images to imaging software took approximately 30 minutes to a few hours. In a few circumstances, large data caused software crashes. Map generation took approximately 10–15 minutes. Susceptibility artifacts varied from mild to moderate in cerebellum, temporal lobes, brainstem, and basal ganglia and none to minimal in the frontal, occipital, and parietal gyri. Map quality was excellent to reasonably good for all cases. The nrCBV, nrCBF, nrMTT, and nrTTP resulted in similar measurements for each anatomic area. Six target lesions were assessed in 2 different patients with well to excellent visualization on fused maps. Three lesions were characterized as tumor progression (1 biopsy-confirmed, 2 unconfirmed), 1 lesion as indeterminant (regressed in follow-up), and 2 lesions as radiation necrosis (1 stable, 1 regressed on follow-up). CONCLUSIONS: Despite limitations with postprocessing issues, it is possible to reliably measure nrCBV, nrCBF, nrMTT, and nrTTP values with DSC perfusion by using a clinical 7T MRI system, and qualitatively, excellent or reasonably good fusion maps can be generated with high resolution. Graphical Abstract


  • Analysis and characterization of interhypothalamic adhesions in adults: No longer only a pediatric finding

    by Onur Tuncer, Alan D Harrell, David Nascene

    Background and purpose: Inter-hypothalamic adhesions (IHAs) are parenchymal tissue bridges traversing the third ventricle, previously reported only in the pediatric population. We aim to understand the prevalence of IHA in the adult population, assess their size and location, and ultimately investigate whether IHA volumes correlate with age. Materials and methods: Patients who underwent routine high-resolution 3D T2WI MRI studies of the temporal bone/internal auditory canal at an otolaryngology clinic between 2008 and 2014 were consecutively selected. The presence of IHAs was confirmed when a parenchymal structure could be traced across the third ventricle, connecting bilateral hypothalamus, and was visible in at least two planes. They were classified based on their location within the third ventricle, considering their connection with hypothalamic nuclei. Patient clinical information were collected from electronic charts. The prevalence and volumes of IHAs were calculated. Associations between age and IHA volume, as well as between IHA type, age, volume, and gender, were analyzed. Results: 779 patients, with a mean age of 54.7 years were included. Among them, 44 IHAs were identified within 41 patients, resulting in a prevalence of 5.26% in our cohort. Type 1 IHA was the most frequently encountered type, comprising 70.5% of all cases. No significant correlation was observed between IHA volumes and age. Additionally, no associations were found between IHA type and age, volume, or gender. Conclusion: IHAs are not exclusive to the pediatric population; they are also present in adults, with a prevalence of 5.26% in patients undergoing temporal bone/internal auditory canal MRI.


  • Open Access

    Artificial Intelligence in Diagnostic Breast Ultrasound: A Comparative Analysis of Decision Support Among Radiologists With Various Levels of Expertise

    by Filiz Çelebi, Onur Tuncer, Müge Oral, Tomris Duymaz, Tolga Orhan, Gökhan Ertaş

    Artificial Intelligence in Diagnostic Breast Ultrasound: A Comparative Analysis of Decision Support Among Radiologists With Various Levels of Expertise - European Journal of Breast Health


  • Open Access

    Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients

    by Ali T. Arafa, Megan Ludwig, Onur Tuncer, Lily Kollitz, Ava Gustafson, Ella Boytim, Christine Luo, Barbara Sabal, Daniel Steinberger, Yingchun Zhao, et al.

    Introduction: Prostate cancer treatment has been revolutionized by targeted therapies, including PARP inhibitors, checkpoint immunotherapies, and PSMA-targeted radiotherapies. Despite such advancements, accurate patient stratification remains a challenge, with current methods relying on genomic markers, tissue staining, and imaging. Extracellular vesicle (EV)-derived proteins offer a novel non-invasive alternative for biomarker discovery, holding promise for improving treatment precision. However, the characterization of plasma-derived EVs in prostate cancer patients remains largely unexplored. Methods: We conducted proteomic analyses on EVs isolated from plasma in 27 metastatic castration-resistant prostate cancer (mCRPC) patients. EVs were purified using ultracentrifugation and analyzed via mass spectrometry. Proteomic data were correlated with clinical markers such as serum prostate-specific antigen (PSA) and bone lesion counts. Statistical significance was assessed using Mann–Whitney t-tests and Spearman correlation. Results: The median age of patients was 74 (range: 44–94) years. At the time of blood collection, the median PSA level was 70 (range: 0.5–1000) ng/mL. All patients had bone metastasis. A total of 5213 proteins were detected, including EV-related proteins (CD9, CD81, CD63, FLOT1, TSG101) and cancer-related proteins (PSMA, B7-H3, PD-L1). Proteomic profiling of plasma EVs revealed a significant correlation between specific EV-derived proteins and clinical prognostic markers. B7-H3, LAT1, and SLC29A1 showed a strong association with serum PSA levels and number of bone lesions, indicating potential for these proteins to serve as biomarkers of disease burden and therapy response. Conclusions: Our findings demonstrate the potential of EV-based proteomics for identifying biomarkers in mCRPC patients. Proteins such as B7-H3 and LAT1 could guide precision oncology approaches, improving patient stratification. Future research incorporating outcomes data and EV subpopulation analysis is needed to establish clinical relevance.


  • Interhypothalamic adhesions: prevalence, structure, and location-based classification map in pediatric patients undergoing MRI

    by Michael P. Oien, Onur Tuncer, David Nascene

    Purpose Interhypothalamic adhesions (IHAs) have been reported only in the pediatric population, with unknown prevalence and histological composition. We aim to demonstrate their prevalence, assess their persistence through longitudinal imaging, classify IHAs by anatomical distribution, explore their structure, and report associated pathologies. Methods A retrospective review was conducted on consecutive pediatric brain MRI studies obtained between January 2012, and December 2013. The presence of an IHA was only confirmed when observed on at least two planes. For each IHA, cross-sectional area was calculated, and signal intensities were measured at the center on sagittal T2WIs. Signal intensities were also measured in both cerebral white matter and gray matter for normalization and comparison. Patient demographics and clinical information were collected from electronic charts. Results Out of 1550 patients (0-17.9 years), 33 (19 males, 14 females) had an IHA, resulting in a 2.13% prevalence. Follow-up images were available for 19 IHA-positive patients, and IHAs were again seen in 92% of the follow-up scans (71/77). Normalized IHA signal highly correlated with normalized gray matter signal (r = 0.83, P < 0.001), but not with normalized white matter signal (r = -0.16, p = 0.494). Common co-occurring pathologies included hydrocephalus (n = 9), prematurity (n = 8), and corpus callosum abnormalities (n = 7). All type 3 IHAs (3/3) were accompanied by pituitary pathologies. Conclusion IHAs have a prevalence of 2.13% in our cohort, and the majority persist in longitudinal studies. They showed gray matter signal intensity and Type 3 IHAs exclusively accompanied pituitary abnormalities.